 » Navigation Menu |
| | | » Epilepsy News | Epilepsy NewsEpilepsy
Neurofeedback
Neuropathy
Epilepsy NewsSBHS grad receives scholarship from Epilepsy Foundation - SOUTH BRUNSWICK — The Epilepsy Foundation of New Jersey has awarded South Brunswick High School graduate Samarth Mehta one of three collegiate scholarships. read more
Concerns raised over epilepsy care - A COUNCILLOR whose daughter suffers from severe epilepsy has called for a greater awareness of the condition in a bid to break the stigma that surrounds it.
US epilepsy drug delay - LONDON - GLAXOSMITHKLINE PLC and Valeant Pharmaceuticals International say they may have to wait an extra three months for the US regulatory review of their potential epilepsy treatment ezogabine. Th...
Specialist Epilepsy Nurse - Software development services from myvillage developers. Feel intense relaxation and wellness accompanied by a deep healing process.
New Action Date for Epilepsy Drug - The FDA has extended the review date for Glaxo and Valeant's epilepsy candidate, ezogabine, by three months.
Stroll for Epilepsy to return to Saratoga Springs Sunday, Sept. 12 - SARATOGA SPRINGS — Heather Straughter knows the toll epilepsy can take on a family.
Valeant, Glaxo Say Epilepsy Drug May Be Delayed - Valeant Pharmaceuticals International, an Aliso Viejo-based drug maker, said Tuesday that it may have to wait another three months for a regulatory review of its epilepsy drug candidate.
Glaxo, Valeant face U.S. delay for epilepsy drug - LONDON - GlaxoSmithKline P.L.C. and Valeant Pharmaceuticals International say they may have to wait an extra three months for the U.S. regulatory review of their potential epilepsy treatment ezogabin...
Glaxo, Valeant May Wait 3 More Months for U.S. FDA to Review Epilepsy Drug - GlaxoSmithKline Plc and Valeant Pharmaceuticals International may have to wait an extra three months for a review of their experimental epilepsy medicine after U.S. regulators sought more time to stu...
Savers to open with a show - NEWINGTON — Savers, a new thrift store at 2064 Woodbury Ave., will celebrate its opening with a fashion show from 5 to 7 p.m. Wednesday, Sept. 8. The show will benefit Savers' signature nonprofit p...
Return to top
Neurofeedback NewsAs Students Head Back to School, neuroAgility Offers Cutting-Edge Treatment for ADHD - Denver - The end of August means one thing for parents and students: back to school.
It Really Is All in Your Head: Neurofeedback Can Change Your Brain - It Really Is All in Your Head: Neurofeedback Can Change Your Brain
Sovereign Health Of California Expands Its Evidence Based Treatment Services By Adding Neurofeedback To Its Program - Sovereign Health of California, a premier behavioral health treatment center located in San Clemente, California, announced that it has further expanded its evidence-based services by adding a neurof...
Six Neurocentric Industries - From forensic MRI scans to neuromarketing, our advancing understanding of the brain will transform society. Here are six examples. In science and in the popular imagination, the brain has become sexy...
Community Calendar - Oak Leaves and Forest Leaves welcome items for the Community Calendar, as well as items for Business Briefs, Campus News, Community Briefs, School Digest and Your Page. Items must be received minimum...
Trade and save in Surrey - You can now trade in old or used baby items at Toys "R" Us in exchange for savings on new products. The Great Trade-In event covers used cribs, strollers, car seats and travel systems.
Brain training boosts acting skills - London, Aug 20 : Daniel Day-Lewis spent months in a wheelchair to prepare for his role in 'My Left Foot'. Similarly, many actors go to extreme lengths to get into their characters. But for actors, wh...
Brain training improves acting skills - Learning to control your brainwaves can help actors give a better performance, say neuroscientists
Return to top
Neuropathy NewsPhotos: Hannah thanks UAlbany - ALBANY -- The family of Hannah Sames, 6, went to the University at Albany on Thursday to thank the campus community for helping "Hannah's Hope" win a $250,000 Pepsi Refresh Grant. UAlbany e...
CEBIX Raises $14.0M - La Jolla-based Cebix, a developer of treatments for type 1 diabetic neuropathy, has raised $14.0M in a new funding round, according to a regulatory filing by the firm today. Details on the funding ha...
Hannah's Hope Wins $250,000! - Thanks to all of you who rallied and voted in the Pepsi Refresh Project, 6-year-old Hannah Sames will be getting help finding a cause and treatment for giant axonal neuropathy, the rare and fatal dis...
Research and Markets: Target Product Profiles 2010: Physician Insights on Key Attributes: Diabetic Neuropathy - DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/9846c1/target_product_pro) has announced the addition of Decision Resources, Inc.'s new report "Target P...
Hannah’s Hope takes second place in the Pepsi Refresh Campaign - After a recent online vote, Hannah’s Hope finished second in the Pepsi Refresh Campaign. With the second-place finish, Tifton’s Lottyn Bates will be helped. Since he was 2 1/2 years old, Bates ha...
Hannah's Hope voters help fund will get $250K - CLIFTON PARK — It’s official, Hannah’s Hope Fund has won $250,000 in prize money from Pepsi.
Hannah's Hope comes in third in national contest - They gave it their best shot. At about midnight, we received word that Hannah's Hope -- a charity named for six-year-old Hannah Sames living with Giant Axonal Neuropathy or GAD -- did not win the $25...
BUSINESS WIRE: Santhera and Ipsen Enter into Licensing Agreement for Fipamezole for the Treatment of Dyskinesia in ... - MITTEILUNG UEBERMITTELT VON BUSINESS WIRE. FUER DEN INHALT IST ALLEIN DAS BERICHTENDE UNTERNEHMEN VERANTWORTLICH.
Alexion Remains Neutral - We are maintaining our Neutral recommendation on Alexion Pharmaceuticals with a target price of $61.
Press Release - Santhera Pharmaceuticals (SIX: SANN) and Ipsen (Paris:IPN) (Euronext: IPN; ADR: IPSEY) today announced a license agreement for the development and commercialization of fipamezole (antagonist of the a...
Return to top
| | | » Stats |
Members: 5,049
Threads: 8,405
Posts: 101,251
| | Welcome to our newest member, athurart09 | |
